A Study to Test How Well Different Doses of BI 3820768 Are Tolerated by People With Advanced Cancer (Solid Tumours) | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study to Test How Well Different Doses of BI 3820768 Are Tolerated by People With Advanced Cancer (Solid Tumours)	Adnexal Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, endocrine system disorder, endometrium neoplasm, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, malignant endocrine neoplasm, neoplasm, ovarian cancer, ovarian disorder, uterine disorder	Recruiting	Phase 1	2026-08-21		NCT07306559

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Boehringer Ingelheim	158

13 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Cliniques Universitaires Saint-Luc	Brussels	Belgium	147
Clínica Universidad de Navarra - Madrid	Madrid	Spain	4
Hospital Universitari Vall d'Hebron	Barcelona	Spain	200
Indiana University	Indianapolis	United States	160
INS Paoli-Calmettes	Marseille	France	3
Institut Gustave Roussy	Villejuif	France	54
Japanese Foundation for Cancer Research	Tokyo, Koto-ku	Japan	11
Klinikum der Universität München AÖR	München	Germany	6
National Cancer Center Hospital East	Chiba, Kashiwa	Japan	13
The University of Texas MD Anderson Cancer Center	Houston	United States	207
Universitätsklinikum Würzburg AÖR	Würzburg	Germany	7
UZ Leuven	Leuven	Belgium	236
Valkyrie Clinical Trials	Los Angeles	United States	47